Company
About us
Acticor Team
Board of Directors
investors & Partners
Prizes & Awards
Our Product
Our product: Glenzocimab
GPVI / GLENZOCIMAB in brief
in acute ischemic stroke
in other indications
Pipeline
About stroke
Key figures
What is a stroke?
Media
Press Releases
Publications
Media Coverage
Events
Investors
Welcome
Corporate Presentation
Share Overview
Shareholders' Meeting
Regulated Information
Financial Agenda
COntact
Investors
Other Regulated Information
pp
2022
2021
PDF
June 7, 2022
Number of shares and voting rights - May 2022
PDF
May 5, 2022
Number of shares and voting rights - April 2022
PDF
April 4, 2022
Number of shares and voting rights - March 2022
PDF
March 3, 2022
Number of shares and voting rights - February 2022
PDF
February 7, 2022
Number of shares and voting rights - January 2022
PDF
January 13, 2022
Half-year Report for liquidity contract - December 31, 2021
PDF
January 13, 2022
Number of shares and voting rights - December 2021
→ Welcome
→ Corporate Presentation
→ Share Overview
→ Shareholders' Meeting
→ Regulated Information
→ Financial Information
→ Other Regulated Information
→ Governance
→ Financial Agenda
→ Contact
Ask Us Your Questions
Subscribe To Email Alert
